Breaking News
Sort by:
Date
Top Post
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Novartis Receives GB Licence for Scemblix®▼ (Asciminib), the First STAMP Inhibitor for Patients With Chronic Myeloid Leukaemia
Novartis UK has announced that Scemblix® (asciminib) has been granted Marketing Authorisation in Great Britain by […]
- iCRYO Announces Partnership with Therapeutic Manufacturer, BTL Read more
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MMP7 for Treatment of Idiopathic Pulmonary Fibrosis Read more
- Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease Read more
- Poseida Therapeutics Announces Board Change Read more
- Digital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi Arabia Read more